AlleCure

AlleCure was a biotechnology company focused on developing novel treatments for allergies and asthma through allergen-specific immunotherapy. The company utilized a proprietary platform to create peptide-based vaccines aimed at desensitizing patients to specific environmental allergens. Its scientific leadership included Dr. Kimishige Ishizaka, the renowned discoverer of IgE, providing a strong mechanistic basis for its drug candidates. In 2001, AlleCure was acquired by MannKind Corporation as part of a strategic move to expand MannKind's portfolio into the immunology space. The company's lead programs targeted common triggers such as ragweed and grass pollen.